188 related articles for article (PubMed ID: 26076048)
1. Stigma from the Viewpoint of the Patient.
Woods JS; Joseph H
J Addict Dis; 2015; 34(2-3):238-47. PubMed ID: 26076048
[TBL] [Abstract][Full Text] [Related]
2. Reducing stigma through education to enhance Medication-Assisted Recovery.
Woods JS; Joseph H
J Addict Dis; 2012; 31(3):226-35. PubMed ID: 22873184
[TBL] [Abstract][Full Text] [Related]
3. Methadone as social control: institutionalized stigma and the prospect of recovery.
Harris J; McElrath K
Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
[TBL] [Abstract][Full Text] [Related]
4. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
McElrath K
Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
[TBL] [Abstract][Full Text] [Related]
5. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
7. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
8. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
Koller G
Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
[No Abstract] [Full Text] [Related]
9. Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew.
Roose R; Fuentes L; Cheema M
Subst Use Misuse; 2012 Aug; 47(10):1117-24. PubMed ID: 22587811
[TBL] [Abstract][Full Text] [Related]
10. Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
Newman RG; Gevertz SG
J Addict Dis; 2011 Oct; 30(4):318-22. PubMed ID: 22026523
[No Abstract] [Full Text] [Related]
11. Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel.
Shidlansik L; Adelson M; Peles E
J Addict Dis; 2017; 36(1):30-37. PubMed ID: 27636020
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
13. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
14. A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.
Kelly SM; Brown BS; Katz EC; O'Grady KE; Mitchell SG; King S; Schwartz RP
Am J Drug Alcohol Abuse; 2012 May; 38(3):233-8. PubMed ID: 22242643
[TBL] [Abstract][Full Text] [Related]
15. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
16. Intervention stigma: How medication-assisted treatment marginalizes patients and providers.
Madden EF
Soc Sci Med; 2019 Jul; 232():324-331. PubMed ID: 31125801
[TBL] [Abstract][Full Text] [Related]
17. Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
Jones HE; Heil SH; Kaltenbach K; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR
J Addict Dis; 2012; 31(4):321-6; discussion 327-8. PubMed ID: 23244549
[No Abstract] [Full Text] [Related]
18. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
McElrath K; Joseph H
Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
[TBL] [Abstract][Full Text] [Related]
19. Underutilization of medications to treat opioid use disorder: What role does stigma play?
Allen B; Nolan ML; Paone D
Subst Abus; 2019; 40(4):459-465. PubMed ID: 31550201
[TBL] [Abstract][Full Text] [Related]
20. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
